Keywords: Forest Labs, Almirall, Aclidinium, COPD, Chelsea Thera, Northera, NOH, Parkinson's USA, FDA advisory panels

FDA panels back Forest and Almirall COPD drug and Chelsea’s Northera for NOH

Article | 24 February 2012

Print This

The US Food and Drug Administration’s Pulmonary-Allergy Drugs Advisory Committee (PADAC) voted 12 to two in favor of approving ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in